Novavax & Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility

Novavax & Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility

Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases has announced that it has finalized an advance purchase agreement (APA) with Gavi, the Vaccine Alliance (Gavi) for the supply of its recombinant protein-based COVID-19 vaccine candidate to the COVAX Facility. Under the APA, Novavax is expected to manufacture and distribute 350 million doses…

Serum Institute of India

Serum Institute of India Launches India’s First Indigenously Developed Pneumococcal Vaccine – PNEUMOSIL®

Pune-based vaccine manufacturer, Serum Institute of India has announced the launch of India’s first indigenously developed pneumococcal vaccine – PNEUMOSIL®. The launch of the vaccine took place in the presence of Dr Harsh Vardhan, Minister of Health and Family Welfare today. PNEUMOSIL® has been developed through a collaboration spanning over a decade among Serum Institute…